近日,青岛高新区在医疗医药产业建圈强链方面捷报频传。世界五百强企业阿斯利康的标牌已经成功挂起,其区域总部将在这里落户。青岛高新区已与阿斯利康正式签署投资合作协议,该项目计划投资4.5亿美元,用于建设布地格福吸入气雾剂(pMDI)国内生产供应基地。投用后,预计可实现年产吸入气雾剂3600万支。
Recently, good news of Qingdao High-Tech Zone in strengthening medical and pharmaceutical industry chain came in quick succession. The logo of AstraZeneca, one of the world’s top 500 companies, has been successfully put up, which means its regional headquarter will be settled here. The zone has officially signed an investment cooperation agreement with AstraZeneca, which plans to invest USD 450 million to build a domestic production base for Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol. It is expected to achieve an annual production capacity of 36 million inhalation aerosols after commissioning.
龙头企业加速落地,领军商会接踵而来。在日前举办的全国工商联医药业商会年度峰会上,全国工商联医药业商会正式入驻青岛高新区,并将打造“全国工商联医药业商会东部医药产业基地”。青岛高新区正不断集聚医疗器械产业链上下游资源,推动医疗医药产业健康发展。